Chemoinformaics analysis of 2-(4-METHYLCYCLOHEX-3-EN-1-YL)PROPAN-2-YL FORMATE
| Molecular Weight | 182.263 | nRot | 3 |
| Heavy Atom Molecular Weight | 164.119 | nRig | 7 |
| Exact Molecular Weight | 182.131 | nRing | 1 |
| Solubility: LogS | -2.894 | nHRing | 0 |
| Solubility: LogP | 3.85 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 2 | APOL | 31.9763 |
| nHD | 0 | BPOL | 20.6617 |
| QED | 0.495 |
| Synth | 3.727 |
| Natural Product Likeliness | 2.143 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.343 |
| MDCK | 0.0000309 |
| BBB | 0.998 |
| PPB | 0.788601 |
| VDSS | 2.79 |
| FU | 0.153374 |
| CYP1A2-inh | 0.4 |
| CYP1A2-sub | 0.239 |
| CYP2c19-inh | 0.247 |
| CYP2c19-sub | 0.609 |
| CYP2c9-inh | 0.122 |
| CYP2c9-sub | 0.661 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.298 |
| CYP3a4-inh | 0.045 |
| CYP3a4-sub | 0.239 |
| CL | 7.017 |
| T12 | 0.501 |
| hERG | 0.004 |
| Ames | 0.003 |
| ROA | 0.017 |
| SkinSen | 0.605 |
| Carcinogencity | 0.956 |
| EI | 0.818 |
| Respiratory | 0.707 |
| NR-Aromatase | 0.005 |
| Antiviral | No |
| Prediction | 0.801566 |